1. At a Glance
When Bhagavad Gita said,“Karmanye vadhikaraste ma phaleshu kadachana,”Lord Krishna clearly didn’t know about the stock market. Because Vasa Denticity’s karma (selling 20,000+ dental SKUs) and itsphala(P/E 64.3×) are both sparkling white – like freshly polished veneers.
At ₹600 a share and a ₹1,040 crore market cap, this tooth fairy of e-commerce sells everything from dental implants to orthodontic drills. But hold your molars — the stock is down about3.2% over the last year, andprofit dipped 7% QoQ, despite a22.4% revenue jumpin Q2FY26. Sales for the quarter stood at₹72.7 crore, withPAT ₹4.99 croreand anOPM of 8.35%.
The company flaunts an enviableROE of 17%andROCE of 23.2%, running its dental empire withzero debtand154 working capital daysthat would make even CA aspirants nervous. Despite no dividends (not even a candy for shareholders), it continues to scale up – acquiring IDS Denmed and biting into India’s biggest integrated dental supply network.
The question now is – will this company keep shining like Colgate’s smile, or develop a cavity in its growth story?
2. Introduction – The Story of the Startup That Went Full Ortho
Once upon a time in 2016, two men looked at a dentist’s chair and thought – “Why not sell the tools online?” That’s howVasa Denticity Ltdwas born, operatingDentalkart.comand its app for India’s ever-expanding army of tooth doctors.
From a100 sq. ft. warehouse in FY17to a43,900 sq. ft. facility in FY25, this company didn’t just grow – it flossed its way into the ₹268 crore sales club.
With76% customer retentionand3.7 lakh monthly active users, they’ve built an e-commerce niche as deep as a root canal. But while their20,000+ SKUsare impressive, maintaininginventory days of 120–150has started testing their molars.
They’ve even raised₹85 crorethroughMalabar Investments and WhiteOak Capital, after a ₹54.5 crore IPO in FY23. What for? More warehouses, more brands, and possibly, more chaos.
Because when you sell “everything dental,” you don’t just compete with other suppliers — you compete with how much patience dentists have left for slow delivery and broken air compressors.
3. Business Model – WTF Do They Even Do?
Imagine Flipkart, but every product either pokes, drills, or bleaches your mouth.
That’s Vasa Denticity’s core business model — anomnichannel dental supply platformofferingconsumables (71.5%),equipment (23.4%), andinstruments (5.1%).
ThroughDentalkart.comand its app, it serves2.2 lakh dental professionalsacross India, including clinics, hospitals, and dental labs.
Their30+ owned brandsare manufactured by third parties, tailored to R&D specifications. Addtie-ups with 300+ global brandslike3M, Dentsply, Ivoclar, and Woodpecker, and you’ve got the Amazon of molar management.
Revenue keeps growing thanks to:
- Consumables– the recurring toothpaste of the business.
- Equipment & Implants– high-margin, but slow moving.
- Digital workflow tools– the “AI” buzzword thrown in for investor applause.
And now, the pièce de résistance –Smile Works Dental Lab, their new venture into prosthetics. Because why just sell a drill when you can make the teeth too?
In essence, they sell hope, hygiene, and hardware – sometimes all in one carton.
4. Financials Overview
| Metric | Latest Qtr (Sep’25) | YoY Qtr (Sep’24) | Prev Qtr (Jun’25) | YoY % | QoQ % |
|---|---|---|---|---|---|
| Revenue | ₹72.72 Cr | ₹59.39 Cr | ₹60.02 Cr | +22.4% | +21.2% |
| EBITDA | ₹6.07 Cr | ₹6.40 Cr | ₹3.16 Cr | -5.2% | +92.1% |
| PAT | ₹4.99 Cr | ₹5.37 Cr | ₹2.87 Cr | -7.1% | +74.0% |
| EPS (₹) | 2.88 | 3.35 | 1.73 | -14.0% | +66.5% |
Annualised EPS = 2.88 × 4 =₹11.52At CMP ₹600, the effectiveP/E = ~52x, slightly below the headline 64x due to growth recovery hopes.
Commentary:Revenue growth looks dental-fresh, but profit
seems to have skipped a cleaning. OPM has fallen from14.28% in Mar’24to8.35%, hinting that logistics and discounting costs are eating into margins. Still, QoQ recovery shows the jawline’s not collapsing yet.
5. Valuation Discussion – Fair Value Range Only
Let’s dissect this smile three ways.
a) P/E Method:Industry median P/E (medical supplies peers) ≈45xVasa EPS (annualized): ₹11.52→ Fair Range = ₹11.52 × 40–50 =₹460 – ₹575
b) EV/EBITDA:EV = ₹1,038 CrEBITDA (TTM) = ₹21 Cr→ EV/EBITDA = 49.4× (very rich)Sector avg ≈ 35× → Adjusted range ₹21 × 35–45 =₹735 – ₹945 Cr EV, implying price range₹520 – ₹670/share
c) Simplified DCF (Educational):Assume FCF margin 3%, growth 20% for 3 years, 10% thereafter, discount rate 12%.→ Fair value band:₹500–₹650/share
🧠Educational Disclaimer:This fair value range is for educational purposes only and isnotinvestment advice.
6. What’s Cooking – News, Triggers, Drama
If this were Netflix, the series would be titled“Game of Molars.”
- August 2025:Announced acquisition of51% stake in IDS Denmedfor ₹128 crore, creatingIndia’s largest dental supply network. That’s like if Flipkart married your neighbourhood dental lab.
- Malabar & WhiteOakjoined the party viapreferential allotment of ₹85 crore, showing institutional molar love.
- Inventory daysballooned to120–150, CFO probably bought a stress ball.
- Smile Works Dental Lablaunched to capture the prosthetic and crown market — because dentists love shiny new margins.
- EGM (Oct 29, 2025):Promoter group reclassified to public – meaning, management’s moving from dentist’s chair to observer’s bench.
The pipeline now includes more warehouses and likely, an omnichannel physical retail experiment. After all, India’s dentists want touch and feel before buying a ₹2 lakh chair.
7. Balance Sheet
| Metric | Mar’23 | Mar’24 | Sep’25 |
|---|---|---|---|
| Total Assets | ₹28 Cr | ₹86 Cr | ₹190 Cr |
| Net Worth (Equity + Reserves) | ₹16 Cr | ₹68 Cr | ₹171 Cr |
| Borrowings | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Other Liabilities | ₹11 Cr | ₹17 Cr | ₹19 Cr |
| Total Liabilities | ₹28 Cr | ₹86 Cr | ₹190 Cr |

